Oral Progestins Lead Heavy Bleeding Treatment
A retrospective study of adolescents and young adults with bleeding disorders found oral progestins were the most effective of five treatment options evaluated.
Updated on Nov. 3, 2026 in Women’s Health
A retrospective study published October 21, 2026, in the Journal of Adolescent Health reviewed 121 adolescents and young adults with bleeding disorders and heavy menstrual bleeding. Oral progestins achieved an 89.8% efficacy rate, outperforming the levonorgestrel-releasing intrauterine system at 81.5% and oral contraceptive pills at 65.5%.
Why it matters
Heavy menstrual bleeding is a common and disruptive problem for young people with bleeding disorders, and oral contraceptive pills are often the first treatment tried. The findings suggest that oral progestins may offer a more effective initial option for this group.
The study, a retrospective review of 121 patients referred between 2016 and 2023, found oral progestins reached 89.8% efficacy in controlling heavy bleeding over a 90-day period, compared with 81.5% for the levonorgestrel-releasing intrauterine system and 65.5% for oral contraceptive pills. Whether these results hold in prospective trials with larger and more diverse populations has not been determined.
The players
Peking University First Hospital
A major teaching hospital in Beijing, China, whose joint pediatric gynecology and pediatric hematology clinic provided the patient population for the study.
The details
Von Willebrand disease was the most common diagnosis, affecting 81 patients, followed by immune thrombocytopenia in 24 patients. Oral contraceptive pills were the most frequently prescribed first therapy at 62.8%, and 58.7% of patients needed two or more regimens before bleeding was adequately controlled, while complete cessation of menstrual bleeding was achieved in 17.4% of patients.
Timeline
Between 2016 and 2023, patients were referred to a joint pediatric gynecology and pediatric hematology clinic.
On October 21, 2026, the study was published online in the Journal of Adolescent Health.
Patients were followed for between 1 and 9 years.
Health Landscape
Management of heavy menstrual bleeding in bleeding disorders has long relied on hormonal therapies with limited comparative evidence, and this retrospective cohort adds data on how common options perform against one another. The findings are preliminary and will require prospective confirmation before they reshape standard practice in adolescent gynecology.
For adolescents and young adults with bleeding disorders who experience heavy periods, oral progestins may be worth discussing with a clinician as a first-line option. Anyone considering a change in treatment should consult a doctor, since the study is retrospective and individual responses vary.
The takeaway
Young people with bleeding disorders and heavy periods have more than one treatment to consider, and efficacy data can help guide that conversation with a clinician. Ask about all available options, including oral progestins, before settling on a regimen.
Further reading
For more on treatment approaches across women's health, explore the Women's Health section.
Source note: This article includes information reported by Medscape.
